Rigel Pharmaceuticals Inc
RIGL
NASDAQ
Biotechnology
$42.58
USD
+1.79 (+4.39%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $780.54M
Volume 224.0K
Price Target
$57.00 – $57.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $57.00 and a min estimate of $57.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$57.00
-$24.0 vs prior
Implied Upside
+33.9%
-56.4% vs prior
Analyst Covering
1
Unchanged vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
50%
A mix of recent and older ratings shape this consensus
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Joseph Pantginis | HC Wainwright & Co. | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
GYRE
Gyre Therapeutics Inc
$6.68
▲ +2.1%
ACHV
Achieve Life Sciences Inc
$7.59
▲ +4.7%
MNPR
Monopar Therapeutics Inc
$113.04
▲ +2.4%
AURA
Aura Biosciences Inc
$7.69
▲ +0.5%
BBOT
BridgeBio Oncology Therapeutics Inc
$9.06
▼ -1.8%
STTK
Shattuck Labs Inc
$7.42
▲ +1.4%
ANNX
Annexon Inc
$5.29
▲ +0.6%
FTH
Faeth Therapeutics, Inc
$32.34
▲ +13.3%
IMMX
Immix Biopharma Inc
$10.97
▲ +0.5%